These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Apropos of emergency management of hemophiliac patients with suspected hemorrhage]. Sultan Y Presse Med; 1999 Mar; 28(11):595-6. PubMed ID: 10214385 [No Abstract] [Full Text] [Related]
4. How I manage patients with inherited haemophilia A and B and factor inhibitors. Ljung RCR Br J Haematol; 2018 Feb; 180(4):501-510. PubMed ID: 29270992 [TBL] [Abstract][Full Text] [Related]
7. Evolving Complexity in Hemophilia Management. Croteau SE Pediatr Clin North Am; 2018 Jun; 65(3):407-425. PubMed ID: 29803274 [TBL] [Abstract][Full Text] [Related]
8. Advances in the care and treatment of children with hemophilia. Manco-Johnson MJ Adv Pediatr; 2010; 57(1):287-94. PubMed ID: 21056743 [No Abstract] [Full Text] [Related]
10. [Emergency management of hemophiliac patients with suspected hemorrhage. National Agency of Accreditation and Evaluation in Health (ANAES)]. Presse Med; 1999 Mar; 28(11):591-5. PubMed ID: 10214384 [No Abstract] [Full Text] [Related]
11. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia. McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730 [TBL] [Abstract][Full Text] [Related]
12. Hemophilia A and B. Shearin-Patterson T; Davidson EJ JAAPA; 2013 Apr; 26(4):49. PubMed ID: 23610840 [No Abstract] [Full Text] [Related]
13. Setting the stage for individualized therapy in hemophilia: What role can pharmacokinetics play? Hazendonk HCAM; van Moort I; Mathôt RAA; Fijnvandraat K; Leebeek FWG; Collins PW; Cnossen MH; Blood Rev; 2018 Jul; 32(4):265-271. PubMed ID: 29426727 [TBL] [Abstract][Full Text] [Related]
14. The treatment of haemophilia, including prophylaxis, constant infusion and DDAVP. Berntorp E Baillieres Clin Haematol; 1996 Jun; 9(2):259-71. PubMed ID: 8800504 [TBL] [Abstract][Full Text] [Related]
15. How do we optimally utilize factor concentrates in persons with hemophilia? Lim MY Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):206-214. PubMed ID: 34889393 [TBL] [Abstract][Full Text] [Related]
16. A golden age for Haemophilia treatment? Makris M; Hermans C Haemophilia; 2018 Mar; 24(2):175-176. PubMed ID: 29601683 [No Abstract] [Full Text] [Related]
17. Haemophilia B: Where are we now and what does the future hold? Dolan G; Benson G; Duffy A; Hermans C; Jiménez-Yuste V; Lambert T; Ljung R; Morfini M; Zupančić Šalek S Blood Rev; 2018 Jan; 32(1):52-60. PubMed ID: 28826659 [TBL] [Abstract][Full Text] [Related]
18. Foundations of hemophilia and epidemiology. Quintana Paris L Blood Coagul Fibrinolysis; 2023 Jun; 34(S1):S35-S36. PubMed ID: 37254731 [TBL] [Abstract][Full Text] [Related]
19. Current concepts in diagnosis and management of hemophilia. Aledort LM Hosp Pract (Off Ed); 1982 Oct; 17(10):77-84, 89-92. PubMed ID: 6811410 [No Abstract] [Full Text] [Related]
20. Looking to the future of gene therapy for hemophilia A and B. Kaczmarek R; Herzog RW Expert Rev Hematol; 2023; 16(11):807-809. PubMed ID: 37798911 [No Abstract] [Full Text] [Related] [Next] [New Search]